The Epic installation — lessons learned so far
“It felt like we were planning the D-Day invasion”
Breaking down business and clinical intelligence
Empowering patients with portals, Stage 2 concerns
The pursuit of personalized medicine
Phyllis Teater, Associate VP/CIO, Wexner Medical Center at The Ohio State University, Chapter 3
07/20/2012 By Leave a Comment
Mark Hulse, CIO, Moffitt Cancer Center, Chapter 1
06/11/2012 By Leave a Comment
The TCC initiative
Finding candidates for research studies
Bringing personalized medicine to cancer care
Building a vendor team to match Moffitt’s vision
Healthcare Is Local, But The Problems Are The Same
03/06/2012 By Leave a Comment
I woke up at 3:30 this morning because I slept half the day yesterday after arriving on a red-eye from HIMSS12 in Las Vegas. We were thrilled that the Annual Conference had record-breaking numbers of attendees and exhibitors. It was a fabulous week of learning and catching up with friends, and I was ready to [...]
Will Bioinformatics Drive Medical Specialty-Specific EHRs?
11/10/2010 By 5 Comments
Over the past several years, we have seen segmentation of EHR product offerings, usually tailored for different clinical settings. In a domain such as Radiology, the specialty requires integration of PACS into the EHR. However, in certain specialties such as oncology, the federal government, professional organizations, and even patient advocacy groups have recommended that the [...]
PODCAST: One-on-One w/University of Texas M. D. Anderson Cancer Center VP & CIO Lynn Vogel, Chapter 5
08/19/2010 By Leave a Comment
While just about every CIO in healthcare can be described as intelligent, only a handful deserve to be called wise. One of those is undoubtedly M. D. Anderson Cancer Center’s Lynn Vogel. And Vogel is not the kind of CIO to keep all that wisdom to himself. As such, he’s an active educator in both [...]
FDA to Recommend New Physician Certification
04/21/2010 By Leave a Comment
The FDA has been receiving a great deal of criticism from the clinical community about a variety of issues, but probably none is as contentious as the ongoing patient safety issues regarding harmful drug-drug interactions and drug-gene interactions, estimated by the Institute of Medicine to cause 250,000 deaths each year in the U.S. The current [...]
Future of the EHR: Exponential Increase in Storage
03/20/2010 By 3 Comments
It’s not just genomic scientists that are dealing with enormous amounts of DNA sequence data – the clinician will soon be next. However, the explosion in linking disease with genetics, and the realization that the FDA will require gene testing prior to the prescription of potentially hundreds of drugs, will challenge the storage capacity required for [...]
PBM versus EHR: Culture Clash?
03/11/2010 By Leave a Comment
Individualizing drug therapy based on pharmacogenomics (PGx) is considered by many academic researchers and clinical experts as the “next significant domain of clinical practice” (see the American College of Clinical Pharmacology’s very informative web-based tutorial, “The Future of Medicine: Pharmacogenomics”, http://user.accp1.org/index_new.html). Drugs that are currently recommended for PGx testing by the FDA include specific medications [...]
